1-2 of 2
Ernest Richards, PhD
Close
Sort by
Journal Articles

Phase Ib-II Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib, w/ Lenalidomide and Rituximab in Relapsed / Refractory Mantle Cell Lymphoma

Andre Goy, MD, Tatyana A Feldman, MD, Lori A. Leslie, MD, Rima Panchal Panchal, Intern, Themba Nyirenda, PhD, Alan P Skarbnik, MD, Kara Yannotti, BSN, Joshua Zenreich, Colleen M Bejot, APN, Susan Stives, APN, Kar Fai Chow, MD, Pritish K. Bhattacharyya, MD, Xiao Yang, Ernest Richards, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2785.
https://doi.org/10.1182/blood.V130.Suppl_1.2785.2785
Published: 2017
Journal Articles

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

Alan P Skarbnik, MD, Michele L. Donato, MD, Scott D. Rowley, MD, Andre Goy, MD, David H. Vesole, MD, Pashna N. Munshi, MD, David Siegel, MD PhD, Noa Biran, MD, Joshua R Richter, MD, Tatyana A Feldman, MD, Lori A. Leslie, MD, Mary E Dilorenzo, APN, Phyllis McKiernan, APN, MSN, Melissa Baker, MSN, ANP, Michele Boonstra, APN, Michele Simone, APN, Ann McNeill, ANP, Ernest Richards, PhD, Joshua Zenreich, Mariefel Vendivil, RN, Andrea Ortega, RN, Jacquelyn Callahan, RN, Michael B Atkins, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 340.
https://doi.org/10.1182/blood.V130.Suppl_1.340.340
Published: 2017